{"id":1139,"date":"2026-10-15T09:36:09","date_gmt":"2026-10-15T09:36:09","guid":{"rendered":"https:\/\/genes2me.com\/blog\/?p=1139"},"modified":"2026-10-15T09:36:09","modified_gmt":"2026-10-15T09:36:09","slug":"from-hla-b27-to-hla-typing-molecular-insights-into-inflammatory-diseases","status":"publish","type":"post","link":"https:\/\/genes2me.com\/blog\/from-hla-b27-to-hla-typing-molecular-insights-into-inflammatory-diseases\/","title":{"rendered":"From HLA-B27 to HLA Typing: Molecular Insights into Inflammatory Diseases"},"content":{"rendered":"\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" src=\"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2026\/10\/image-4.jpeg\" alt=\"\" class=\"wp-image-1141\" width=\"857\" height=\"375\" srcset=\"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2026\/10\/image-4.jpeg 624w, https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2026\/10\/image-4-300x131.jpeg 300w\" sizes=\"(max-width: 857px) 100vw, 857px\" \/><\/figure>\n\n\n\n<h1>The Clinical Challenge<\/h1>\n\n\n\n<p>Arjun is 28. He writes code for a living, plays cricket on weekends, and for almost a year, every morning has started the same way: stiff. His lower back feels locked when he wakes up, and it only eases after he has been moving around for a while. He blamed his chair, then his mattress, then his long hours at the laptop.<\/p>\n\n\n\n<p>But some things didn&#8217;t fit. Rest made the pain worse, and movement made it better. Last winter he also had a painful red eye that his doctor called uveitis. That pattern is what makes a clinician stop and ask whether this is <strong>inflammation<\/strong> rather than ordinary back strain.<\/p>\n\n\n\n<p>Arthritis is not one disease. It is a large family of conditions, some driven by wear and tear, some by inflammation, and some by the immune system turning on the body&#8217;s own tissues. Telling them apart usually takes several things together: a clinical evaluation, laboratory tests and imaging. Arjun&#8217;s symptoms point towards the <strong>spondyloarthropathies<\/strong>, a group of inflammatory conditions that affect the spine and sacroiliac joints. In these conditions, genetics can add a useful clue.<\/p>\n\n\n\n<h1>Understanding HLA and Its Role in Immune Function<\/h1>\n\n\n\n<p>Imagine every cell in your body wearing an ID badge that tells the immune system what is happening inside it. Those badges are made by the <strong><a href=\"https:\/\/www.genes2me.com\/ngs\/transplant-immunology\/human-leukocyte-antigen-detection-panel\">human leukocyte antigen (HLA)<\/a><\/strong> genes. HLA proteins present small protein fragments to immune cells, helping the body tell &#8220;self&#8221; from &#8220;non-self&#8221; and decide when to respond.<\/p>\n\n\n\n<p>HLA genes are among the most variable in the human genome, and certain variants are linked with particular diseases. Even so, <strong>an association is not a diagnosis<\/strong>: many people carry disease-associated HLA variants and never develop the condition.<\/p>\n\n\n\n<h1>HLA-B27: A Key Genetic Marker in Spondyloarthritis<\/h1>\n\n\n\n<p>One variant stands out in rheumatology: <strong><a href=\"https:\/\/www.genes2me.com\/ivd-real-time-pcr\/oncology-diagnostics-solutions\/hla-b27-q-realtime-pcr-kit\">HLA-B27<\/a><\/strong>. It is one of the best-established genetic markers of <strong>axial spondyloarthritis (axSpA)<\/strong>, a chronic inflammatory condition that mainly affects the spine and sacroiliac joints. Ankylosing spondylitis is the form of axSpA in which changes are visible on X-ray.<\/p>\n\n\n\n<p>HLA-B27 testing is recommended when axSpA is suspected, especially in people with:<\/p>\n\n\n\n<ul><li>Persistent back pain that began before the age of 45<\/li><li>Back pain with inflammatory features, such as morning stiffness that improves with movement<\/li><li>A history of uveitis, psoriasis or inflammatory bowel disease<\/li><li>Other clinical findings suggestive of spondyloarthritis<\/li><\/ul>\n\n\n\n<p>Arjun matches the list almost line by line. Still, a positive result does not confirm the disease on its own, and a negative result does not rule it out. HLA-B27 is a clue, not a verdict.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" src=\"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2026\/10\/image-5.png\" alt=\"\" class=\"wp-image-1142\" width=\"840\" height=\"365\" srcset=\"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2026\/10\/image-5.png 624w, https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2026\/10\/image-5-300x130.png 300w\" sizes=\"(max-width: 840px) 100vw, 840px\" \/><\/figure>\n\n\n\n<p><em>Figure 1. HLA-B27 adds weight to the clinical picture; it is interpreted alongside symptoms, examination, blood markers and imaging.<\/em><\/p>\n\n\n\n<h1>HLA-B27 Testing with Real-Time PCR: Introducing G2M\u2019s HLA B27-Q Kit<\/h1>\n\n\n\n<p>So how does the lab answer the question, &#8220;Is HLA-B27 present?&#8221; <strong><a href=\"https:\/\/www.genes2me.com\/instruments\/real-time-pcr-system\">Real-Time PCR<\/a><\/strong> amplifies a specific DNA sequence and tracks a fluorescent signal as it does. That makes it fast and targeted, which is ideal for a focused question.<\/p>\n\n\n\n<p>The <strong>G2M HLA-B27-Q Real-Time PCR Kit<\/strong> is a qualitative in vitro diagnostic (IVD) assay that detects the HLA-B27 allele in human clinical samples, including whole blood. Its multiplex design pairs specific primers and fluorescent probes with an <strong>internal control<\/strong> that monitors every reaction. The kit is intended for use by appropriately trained, semi-skilled laboratory professionals.<\/p>\n\n\n\n<h1>Beyond a Single Marker: What Is HLA Typing?<\/h1>\n\n\n\n<p>Arjun&#8217;s question was narrow. Many questions in immunogenetics are broader: exactly which HLA alleles does a person carry, across many HLA genes, at high resolution? That is what <strong>HLA typing<\/strong> answers. It has established roles in <strong>transplant compatibility assessment<\/strong> and <strong>immunogenetic research<\/strong>, including studies of how HLA variation relates to inflammatory disease. It is not, however, a universal diagnostic test for arthritis. Its value depends on the loci analysed and the question being asked.<\/p>\n\n\n\n<h1>HLA Typing Through NGS: The G2M HLA Typing NGS Panel<\/h1>\n\n\n\n<p><strong><a href=\"https:\/\/www.genes2me.com\/next-generation-sequencing-clinical-panels\">Next-generation sequencing (NGS)<\/a><\/strong> reads many DNA regions in parallel, which suits the HLA region, the most densely polymorphic part of the genome. The <strong>Genes2Me HLA Typing NGS Panel<\/strong> delivers high-resolution, <strong>phase-resolved<\/strong> results: it shows not only which variants are present but which ones sit together on the same copy of a gene. The result is unambiguous typing that supports confident donor selection in transplantation.<\/p>\n\n\n\n<ul><li><strong>11 loci in one tube:<\/strong> Class I (HLA-A, B, C) and Class II (DPA1, DPB1, DQA1, DQB1, DRB1, DRB3, DRB4, DRB5)<\/li><li><strong>Whole coding sequence<\/strong>, a target size of about 71 kb, from blood samples<\/li><li><strong>Hybridisation capture<\/strong> enrichment, which improves sensitivity and reduces PCR bias such as allele drop-outs<\/li><li><strong>Platform-agnostic<\/strong> libraries (200\u2013700 bp) and an end-to-end CE-IVD workflow, from extraction to reporting<\/li><li><strong>Validated performance<\/strong> (Illumina platform): 100% sensitivity, 99% reproducibility, 98% coverage uniformity and an 85% on-target ratio<\/li><\/ul>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" src=\"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2026\/10\/image-6.png\" alt=\"\" class=\"wp-image-1143\" width=\"849\" height=\"399\" srcset=\"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2026\/10\/image-6.png 624w, https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2026\/10\/image-6-300x141.png 300w\" sizes=\"(max-width: 849px) 100vw, 849px\" \/><\/figure>\n\n\n\n<p><em>Figure 2. The G2M HLA Typing NGS workflow and the 11 HLA loci it covers.<\/em><\/p>\n\n\n\n<p><\/p>\n\n\n\n<h1>Real-Time PCR and NGS: Different Approaches, Distinct Objectives<\/h1>\n\n\n\n<p>These technologies are not competitors, and not every patient needs both. Real-Time PCR gives targeted detection of a single marker; NGS characterises many HLA loci in depth. They are <strong>complementary<\/strong>, and the right choice depends on the clinical or research question.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" width=\"624\" height=\"282\" src=\"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2026\/10\/image-7.png\" alt=\"\" class=\"wp-image-1144\" srcset=\"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2026\/10\/image-7.png 624w, https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2026\/10\/image-7-300x136.png 300w\" sizes=\"(max-width: 624px) 100vw, 624px\" \/><\/figure>\n\n\n\n<p><em>Figure 4. Choosing the right tool for the right question.<\/em><\/p>\n\n\n\n<h1>Integrating Molecular Results into Clinical Assessment<\/h1>\n\n\n\n<p>Arjun&#8217;s HLA-B27 result came back positive. On its own, it didn&#8217;t diagnose him. What it did was add weight to everything else his rheumatologist saw: early onset, inflammatory back pain, a history of uveitis, raised inflammatory markers and findings on MRI. Together, the picture was clear enough to start treatment aimed at the inflammation, not at his chair. Had the result been negative, his doctor would have kept looking.<\/p>\n\n\n\n<p>That is the real lesson: <strong>a genetic result is most powerful when it is interpreted, not just reported.<\/strong><\/p>\n\n\n\n<h1>Conclusion<\/h1>\n\n\n\n<p><a href=\"https:\/\/www.genes2me.com\/\">Molecular diagnostics<\/a> add valuable genetic insight to the assessment of selected inflammatory conditions. Targeted HLA-B27 detection by Real-Time PCR and high-resolution HLA typing by NGS each serve a distinct purpose. At <strong>G2M<\/strong>, we continue to advance molecular diagnostics with solutions for both, so that labs and clinicians can choose the right tool for every patient&#8217;s story.<\/p>\n\n\n\n<p><em>Arjun is an illustrative composite, not a real patient. This article is for general information and is not medical advice.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Clinical Challenge Arjun is 28. He writes code for a living, plays cricket on weekends, and for almost a year, every morning has started&hellip;<\/p>\n","protected":false},"author":1,"featured_media":1145,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v19.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>From HLA-B27 to HLA Typing: Molecular Insights into Inflammatory Diseases - Genes2Me Blog - CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/genes2me.com\/blog\/from-hla-b27-to-hla-typing-molecular-insights-into-inflammatory-diseases\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"From HLA-B27 to HLA Typing: Molecular Insights into Inflammatory Diseases - Genes2Me Blog - CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems\" \/>\n<meta property=\"og:description\" content=\"The Clinical Challenge Arjun is 28. He writes code for a living, plays cricket on weekends, and for almost a year, every morning has started&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/genes2me.com\/blog\/from-hla-b27-to-hla-typing-molecular-insights-into-inflammatory-diseases\/\" \/>\n<meta property=\"og:site_name\" content=\"Genes2Me Blog - CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-15T09:36:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2026\/10\/HLA-B27-to-HLA-Typing-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"700\" \/>\n\t<meta property=\"og:image:height\" content=\"525\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Genes2Me\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Genes2Me\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Organization\",\"@id\":\"https:\/\/genes2me.com\/blog\/#organization\",\"name\":\"Genes2Me Blog - CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems\",\"url\":\"https:\/\/genes2me.com\/blog\/\",\"sameAs\":[],\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/genes2me.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2023\/09\/cropped-G2M150x150.jpg\",\"contentUrl\":\"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2023\/09\/cropped-G2M150x150.jpg\",\"width\":150,\"height\":69,\"caption\":\"Genes2Me Blog - CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems\"},\"image\":{\"@id\":\"https:\/\/genes2me.com\/blog\/#\/schema\/logo\/image\/\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/genes2me.com\/blog\/#website\",\"url\":\"https:\/\/genes2me.com\/blog\/\",\"name\":\"Genes2Me Blog - CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems\",\"description\":\"Real Time PCR Molecular Diagnostics NGS Cancer Screening Sequencing COVID-19 Rapid Antigen Antibody Made in India Manufacturer Clinical\/Whole Exome\",\"publisher\":{\"@id\":\"https:\/\/genes2me.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/genes2me.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/genes2me.com\/blog\/from-hla-b27-to-hla-typing-molecular-insights-into-inflammatory-diseases\/\",\"url\":\"https:\/\/genes2me.com\/blog\/from-hla-b27-to-hla-typing-molecular-insights-into-inflammatory-diseases\/\",\"name\":\"From HLA-B27 to HLA Typing: Molecular Insights into Inflammatory Diseases - Genes2Me Blog - CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems\",\"isPartOf\":{\"@id\":\"https:\/\/genes2me.com\/blog\/#website\"},\"datePublished\":\"2026-10-15T09:36:09+00:00\",\"dateModified\":\"2026-10-15T09:36:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/genes2me.com\/blog\/from-hla-b27-to-hla-typing-molecular-insights-into-inflammatory-diseases\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/genes2me.com\/blog\/from-hla-b27-to-hla-typing-molecular-insights-into-inflammatory-diseases\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/genes2me.com\/blog\/from-hla-b27-to-hla-typing-molecular-insights-into-inflammatory-diseases\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/genes2me.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"From HLA-B27 to HLA Typing: Molecular Insights into Inflammatory Diseases\"}]},{\"@type\":\"Article\",\"@id\":\"https:\/\/genes2me.com\/blog\/from-hla-b27-to-hla-typing-molecular-insights-into-inflammatory-diseases\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/genes2me.com\/blog\/from-hla-b27-to-hla-typing-molecular-insights-into-inflammatory-diseases\/\"},\"author\":{\"name\":\"Genes2Me\",\"@id\":\"https:\/\/genes2me.com\/blog\/#\/schema\/person\/10206ca125f3a19893d76130599c48aa\"},\"headline\":\"From HLA-B27 to HLA Typing: Molecular Insights into Inflammatory Diseases\",\"datePublished\":\"2026-10-15T09:36:09+00:00\",\"dateModified\":\"2026-10-15T09:36:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/genes2me.com\/blog\/from-hla-b27-to-hla-typing-molecular-insights-into-inflammatory-diseases\/\"},\"wordCount\":1025,\"publisher\":{\"@id\":\"https:\/\/genes2me.com\/blog\/#organization\"},\"articleSection\":[\"Dignostic Solution\"],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/genes2me.com\/blog\/#\/schema\/person\/10206ca125f3a19893d76130599c48aa\",\"name\":\"Genes2Me\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/genes2me.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d657e6ab646ef1896bc855e2b96e924e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d657e6ab646ef1896bc855e2b96e924e?s=96&d=mm&r=g\",\"caption\":\"Genes2Me\"},\"description\":\"Established in 2016, Genes2Me is a leading molecular diagnostics company committed to transforming healthcare through innovative, high-quality in vitro diagnostic (IVD) solutions. Built on a strong foundation of scientific excellence and precision engineering, Genes2Me develops and manufactures advanced diagnostic technologies that enable accurate, reliable, and timely clinical decision-making across diverse healthcare settings worldwide. With a comprehensive and rapidly expanding portfolio, Genes2Me offers cutting-edge solutions across molecular diagnostics, including Next Generation Sequencing (NGS) clinical assays, point-of-care (POC) testing platforms, RT-PCR kits and instruments, as well as nucleic acid extraction kits and automation systems. Designed to meet the evolving needs of modern laboratories and clinicians, our products combine performance, scalability, and operational efficiency. A vast majority of Genes2Me products are CE-IVD marked, reflecting our commitment to global quality benchmarks, regulatory compliance, and uncompromising product standards. At the heart of our innovation are proprietary platforms such as OnePCR and Rapi-Q, developed to deliver rapid, multiplex, and highly sensitive molecular detection with streamlined workflows and minimal turnaround time. OnePCR integrates automated nucleic acid extraction and RT-PCR into a single, seamless workflow, enabling the detection of up to 20 targets from a single sample with exceptional precision and efficiency. The Rapi-Q series is engineered for fast, sensitive, and multiplex testing with a larger throughput, empowering healthcare providers with timely diagnostic insights that support improved patient outcomes. In genomics, Genes2Me offers one of the industry\u2019s most comprehensive NGS clinical assay portfolios, spanning oncology, liquid biopsy, whole exome sequencing, NIPT and pharmacogenomics. Complementing this portfolio is EZY AutoPrep, our advanced automated library preparation workstation designed to optimize NGS library preparation through enhanced accuracy, reproducibility, and scalability. Our genomics ecosystem is further strengthened by CliSeq Interpreter, a cloud-based bioinformatics platform that enables accurate, flexible, and intuitive interpretation of complex genomic data, helping laboratories generate high-confidence insights with efficiency and ease. Driven by innovation, quality, and a global vision, Genes2Me continues to redefine the future of molecular diagnostics\u2014delivering integrated solutions that advance precision medicine and improve lives worldwide.\",\"sameAs\":[\"https:\/\/www.genes2me.com\/\"],\"url\":\"https:\/\/genes2me.com\/blog\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"From HLA-B27 to HLA Typing: Molecular Insights into Inflammatory Diseases - Genes2Me Blog - CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/genes2me.com\/blog\/from-hla-b27-to-hla-typing-molecular-insights-into-inflammatory-diseases\/","og_locale":"en_US","og_type":"article","og_title":"From HLA-B27 to HLA Typing: Molecular Insights into Inflammatory Diseases - Genes2Me Blog - CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems","og_description":"The Clinical Challenge Arjun is 28. He writes code for a living, plays cricket on weekends, and for almost a year, every morning has started&hellip;","og_url":"https:\/\/genes2me.com\/blog\/from-hla-b27-to-hla-typing-molecular-insights-into-inflammatory-diseases\/","og_site_name":"Genes2Me Blog - CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems","article_published_time":"2026-10-15T09:36:09+00:00","og_image":[{"width":700,"height":525,"url":"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2026\/10\/HLA-B27-to-HLA-Typing-1.jpg","type":"image\/jpeg"}],"author":"Genes2Me","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Genes2Me","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Organization","@id":"https:\/\/genes2me.com\/blog\/#organization","name":"Genes2Me Blog - CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems","url":"https:\/\/genes2me.com\/blog\/","sameAs":[],"logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/genes2me.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2023\/09\/cropped-G2M150x150.jpg","contentUrl":"https:\/\/genes2me.com\/blog\/wp-content\/uploads\/2023\/09\/cropped-G2M150x150.jpg","width":150,"height":69,"caption":"Genes2Me Blog - CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems"},"image":{"@id":"https:\/\/genes2me.com\/blog\/#\/schema\/logo\/image\/"}},{"@type":"WebSite","@id":"https:\/\/genes2me.com\/blog\/#website","url":"https:\/\/genes2me.com\/blog\/","name":"Genes2Me Blog - CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems","description":"Real Time PCR Molecular Diagnostics NGS Cancer Screening Sequencing COVID-19 Rapid Antigen Antibody Made in India Manufacturer Clinical\/Whole Exome","publisher":{"@id":"https:\/\/genes2me.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/genes2me.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/genes2me.com\/blog\/from-hla-b27-to-hla-typing-molecular-insights-into-inflammatory-diseases\/","url":"https:\/\/genes2me.com\/blog\/from-hla-b27-to-hla-typing-molecular-insights-into-inflammatory-diseases\/","name":"From HLA-B27 to HLA Typing: Molecular Insights into Inflammatory Diseases - Genes2Me Blog - CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems","isPartOf":{"@id":"https:\/\/genes2me.com\/blog\/#website"},"datePublished":"2026-10-15T09:36:09+00:00","dateModified":"2026-10-15T09:36:09+00:00","breadcrumb":{"@id":"https:\/\/genes2me.com\/blog\/from-hla-b27-to-hla-typing-molecular-insights-into-inflammatory-diseases\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/genes2me.com\/blog\/from-hla-b27-to-hla-typing-molecular-insights-into-inflammatory-diseases\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/genes2me.com\/blog\/from-hla-b27-to-hla-typing-molecular-insights-into-inflammatory-diseases\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/genes2me.com\/blog\/"},{"@type":"ListItem","position":2,"name":"From HLA-B27 to HLA Typing: Molecular Insights into Inflammatory Diseases"}]},{"@type":"Article","@id":"https:\/\/genes2me.com\/blog\/from-hla-b27-to-hla-typing-molecular-insights-into-inflammatory-diseases\/#article","isPartOf":{"@id":"https:\/\/genes2me.com\/blog\/from-hla-b27-to-hla-typing-molecular-insights-into-inflammatory-diseases\/"},"author":{"name":"Genes2Me","@id":"https:\/\/genes2me.com\/blog\/#\/schema\/person\/10206ca125f3a19893d76130599c48aa"},"headline":"From HLA-B27 to HLA Typing: Molecular Insights into Inflammatory Diseases","datePublished":"2026-10-15T09:36:09+00:00","dateModified":"2026-10-15T09:36:09+00:00","mainEntityOfPage":{"@id":"https:\/\/genes2me.com\/blog\/from-hla-b27-to-hla-typing-molecular-insights-into-inflammatory-diseases\/"},"wordCount":1025,"publisher":{"@id":"https:\/\/genes2me.com\/blog\/#organization"},"articleSection":["Dignostic Solution"],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/genes2me.com\/blog\/#\/schema\/person\/10206ca125f3a19893d76130599c48aa","name":"Genes2Me","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/genes2me.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d657e6ab646ef1896bc855e2b96e924e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d657e6ab646ef1896bc855e2b96e924e?s=96&d=mm&r=g","caption":"Genes2Me"},"description":"Established in 2016, Genes2Me is a leading molecular diagnostics company committed to transforming healthcare through innovative, high-quality in vitro diagnostic (IVD) solutions. Built on a strong foundation of scientific excellence and precision engineering, Genes2Me develops and manufactures advanced diagnostic technologies that enable accurate, reliable, and timely clinical decision-making across diverse healthcare settings worldwide. With a comprehensive and rapidly expanding portfolio, Genes2Me offers cutting-edge solutions across molecular diagnostics, including Next Generation Sequencing (NGS) clinical assays, point-of-care (POC) testing platforms, RT-PCR kits and instruments, as well as nucleic acid extraction kits and automation systems. Designed to meet the evolving needs of modern laboratories and clinicians, our products combine performance, scalability, and operational efficiency. A vast majority of Genes2Me products are CE-IVD marked, reflecting our commitment to global quality benchmarks, regulatory compliance, and uncompromising product standards. At the heart of our innovation are proprietary platforms such as OnePCR and Rapi-Q, developed to deliver rapid, multiplex, and highly sensitive molecular detection with streamlined workflows and minimal turnaround time. OnePCR integrates automated nucleic acid extraction and RT-PCR into a single, seamless workflow, enabling the detection of up to 20 targets from a single sample with exceptional precision and efficiency. The Rapi-Q series is engineered for fast, sensitive, and multiplex testing with a larger throughput, empowering healthcare providers with timely diagnostic insights that support improved patient outcomes. In genomics, Genes2Me offers one of the industry\u2019s most comprehensive NGS clinical assay portfolios, spanning oncology, liquid biopsy, whole exome sequencing, NIPT and pharmacogenomics. Complementing this portfolio is EZY AutoPrep, our advanced automated library preparation workstation designed to optimize NGS library preparation through enhanced accuracy, reproducibility, and scalability. Our genomics ecosystem is further strengthened by CliSeq Interpreter, a cloud-based bioinformatics platform that enables accurate, flexible, and intuitive interpretation of complex genomic data, helping laboratories generate high-confidence insights with efficiency and ease. Driven by innovation, quality, and a global vision, Genes2Me continues to redefine the future of molecular diagnostics\u2014delivering integrated solutions that advance precision medicine and improve lives worldwide.","sameAs":["https:\/\/www.genes2me.com\/"],"url":"https:\/\/genes2me.com\/blog\/author\/admin\/"}]}},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/posts\/1139"}],"collection":[{"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/comments?post=1139"}],"version-history":[{"count":1,"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/posts\/1139\/revisions"}],"predecessor-version":[{"id":1146,"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/posts\/1139\/revisions\/1146"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/media\/1145"}],"wp:attachment":[{"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/media?parent=1139"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/categories?post=1139"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/genes2me.com\/blog\/wp-json\/wp\/v2\/tags?post=1139"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}